COVANCE INTRODUCES IVRS EXPRESS SERVICES FOR PATIENT ENROLLMENT, RANDOMIZATION AND DRUG SUPPLY MANAGEMENT

Princeton, New Jersey, April 29, 2006 — Covance (NYSE: CVD) today announced the availability of the Covance Express SuiteSM of Interactive Voice Response Services (IVRS) — affordable, fast start-up IVRS solutions for small, non-complex clinical trials. The Express Suite comprises pre-configured solutions to address the most common patient enrollment, randomization, and drug supply management needs of biopharmaceutical firms sponsoring trials and studies where automated methods have not previously been a viable or cost-effective option. The Express Suite provides sponsors with a study-wide view of patient and drug supply activity enabling them to monitor progress, anticipate problems, and take preventive actions before they occur.

"Small and non-complex clinical studies are frequently burdened with error-prone manual processes, and unfortunately electronic data capture — with hand-held devices or even traditional interactive voice response technology — has been seen as too expensive, too complex and difficult to get off the ground," said Jim Denmark, General Manager of Covance IVRS. "With the Express Suite, Covance is delivering the best of all worlds — a fast start-up, affordable, off-the-shelf solution, with the benefit of automated data capture, analysis, and reporting, all backed by Covance's extensive clinical expertise."

To finish the reading, please visit us at http://www.covance.com/news/pressrel/2006/060410.php